Article

COVID-19 and the Generation of Novel Scientific Knowledge in a Dangerous Time.

2020-12-23

Abstract excerpt

Rationale, Aims and Objectives: One of the sectors challenged by the COVID-19 pandemic is medical research. COVID-19 originates from a novel coronavirus (SARS-CoV-2) and the scientific community is faced with the daunting task of creating a novel model for this pandemic or, in other words, creating novel science. This paper aims to explore the intricate relationship between the different challenges that have hinde...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7c02a3e7-dc29-5402-92e1-b398d578066b
DOI: 10.22541/au.160873142.24986879/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 and the Generation of Novel Scientific Knowledge in a Dangerous Time.DOI 10.22541/au.160873142.24986879/v1Read

Global landscape of randomized controlled trials responding to the COVID-19 pandemic: a literature review protocolSemantic proximity Read

Public health measures for covid-19Semantic proximity Read

HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIALSemantic proximity Read

How the clinical research community responded to the COVID-19 pandemic: An analysis of the COVID-19 clinical studies in ClinicalTrials.govSemantic proximity Read

Characteristics of scientific articles on COVID-19 published during the initial three months of the pandemic: a meta-epidemiological studySemantic proximity Read

Creating equity in health research to drive more and better evidenceSemantic proximity Read

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trialSemantic proximity Read

Hydroxychloroquine/Chloroquine in COVID-19 With Focus on Hospitalized Patients – A Systematic ReviewSemantic proximity Read

Pooled evidence precision of clinical trials on hydroxychloroquine for Covid-19 treatment was stabilized eight months after the outbreakSemantic proximity Read

Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009Semantic proximity Read

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.Semantic proximity Read

Comparative <i>in vitro</i> transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genesSemantic proximity Read